Coreline secures FDA nod for lung nodule detection software

By staff writers

May 1, 2023 -- Advanced visualization and artificial intelligence (AI) software developer Coreline Soft has received clearance from the U.S. Food and Drug Administration (FDA) for its Aview LCS lung cancer screening computer-aided detection software.

Aview LCS helps clinicians identify and characterize lung nodules on low-dose CT (LDCT), cutting imaging interpretation time by 70%, increasing sensitivity by 34%, and decreasing false positives by 42%, according to Coreline Soft.

Copyright © 2023

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking